文献速递小儿耳鼻咽喉耳科与耳神经

澳大利亚学龄前儿童听力损失筛查的成本效果分析

Cost-Effectiveness of Screening Preschool Children for Hearing Loss in Australia.
PubMed 文献 · Ear Hear · 2022-01-01

该研究采用决策分析模型,评估在澳大利亚使用Sound Scouts家庭自测应用筛查5岁儿童听力损失、与不筛查相比的成本效果。结果显示,筛查组人均增量成本为61.02澳元,增量质量调整生命年(QALY)为0.01,增量成本效果比为每获得一个QALY需5392澳元。在每QALY 60000澳元的支付意愿阈值下,筛查具有成本效果的概率为96.2%。作者认为使用Sound Scouts筛查5岁儿童听力损失可能具有成本效果。

要点

  • 使用Sound Scouts筛查5岁儿童听力损失,估计增量成本为61.02澳元、增量QALY为0.01。
  • 增量成本效果比为每QALY 5392澳元,在60000澳元/QALY阈值下96.2%概率具有成本效果。
  • 作者认为筛查可早期识别和干预儿童听力损失,减少童年期劣势。

核心结论

  • 使用Sound Scouts在家庭环境中筛查5岁儿童听力损失可能具有成本效果。
  • 筛查有助于早期识别和干预儿童听力损失,通过终身质量、教育和经济结局的累积获益减少早期童年劣势。

研究设计与样本

  • 研究采用决策分析模型,估计使用Sound Scouts筛查与不筛查相比的增量成本和QALY,时间跨度为20年。
  • 模型参数中,测试准确性基于Sound Scouts测试结果与临床测试结果的比较,其他参数基于已发表数据。
  • 成本从澳大利亚医疗保健系统视角估算,并进行了单因素和概率敏感性分析。

主要发现

  • Sound Scouts筛查估计产生平均增量成本61.02澳元,平均增量QALY为0.01。
  • 增量成本效果比为每获得一个QALY需5392澳元。
  • 在每QALY 60000澳元的阈值下,Sound Scouts筛查具有成本效果的概率为96.2%。

关键数值与推荐

  • Sound Scouts是一款听力筛查应用程序,由家长在家中监督,使用平板电脑或移动设备测试儿童听力损失。
  • 该应用测试感音神经性或永久性传导性听力损失以及中枢听觉处理障碍。
  • 2018年澳大利亚政府资助推广Sound Scouts,允许最多600000名儿童使用Sound Scouts测试听力。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: While all newborns in Australia are tested for congenital hearing loss through universal newborn hearing screening programs, some children will acquire hearing loss in their first five years of life. Delayed diagnosed or undiagnosed hearing loss in children can have substantial immediate- and long-term consequences. It can significantly reduce school readiness, language and communication development, social and emotional development, and mental health. It can also compromise lifetime educational achievements and employment opportunities and future economic contribution to society through lost productivity. The need for a universal hearing screening program for children entering their first year of primary school has been noted in two separate Australian Government hearing inquiries in the last decade. Sound Scouts is a hearing screening application (app) that tests for hearing loss in children using a tablet or mobile device, supervised by parents at home. It tests for sensorineural or permanent conductive hearing loss and central auditory processing disorder in children. In 2018 the Australian Government funded the roll-out of Sound Scouts to allow up to 600,000 children to test their hearing using Sound Scouts. This study estimated the cost-effectiveness of screening 5-year-old children for hearing loss using Sound Scouts at home, compared with no screening. DESIGN: A decision-analytic model was developed to estimate the incremental costs and quality-adjusted life years (QALYs) of administering Sound Scouts over a 20-year time horizon. Testing accuracy was based on comparing Sound Scouts test results to clinical test results while other parameters were based on published data. Costs were estimated from the perspective of the Australian health care system. Univariate and probabilistic sensitivity analyses were undertaken. RESULTS: Sound Scouts is estimated to result in an average incremental cost of A$61.02 and an average incremental increase in QALYs of 0.01. This resulted in an incremental cost-effectiveness ratio of A$5392 per QALY gained, which is likely to be considered cost-effective by Australian decision makers. Screening with Sound Scouts was found to have a 96.2 per cent probability of being cost-effective using a threshold of A$60,000 per QALY gained. CONCLUSIONS: Using Sound Scouts to screen five-year-old children for hearing loss (at home) is likely to be cost-effective. Screening children using Sound Scouts will result in early identification and intervention in childhood hearing loss, thereby reducing early childhood disadvantage through cumulative gains in quality of life, education, and economic outcomes over their lifetime.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Gumbie M, Parkinson B, Dillon H, et al. Cost-Effectiveness of Screening Preschool Children for Hearing Loss in Australia. Ear Hear. 2022. PMID: 34753856. doi:10.1097/AUD.0000000000001134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。